Stocks
Eli Lilly Nears $2B-Plus Kelonia Deal for Cancer Pipeline
Eli Lilly is in advanced talks to acquire Kelonia Therapeutics for over $2 billion, aiming to expand its cancer pipeline, The Wall...
Eli Lilly is in advanced talks to acquire Kelonia Therapeutics for over $2 billion, aiming to expand its cancer pipeline, The Wall...